ATHE — ALTERITY THERAPEUTICS
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Wall Street Analyst Consensus
Ratings, 12-month price target and EPS forecasts from the Nasdaq public analyst feed. · Fetched 2026-11-19
| Fiscal year end | Consensus EPS forecast | Forward P/E | High EPS | Low EPS | # estimates | Revisions (4wk up/down) |
|---|---|---|---|---|---|---|
| Jun 2027 | -0.12 | — | -0.12 | -0.12 | 1 | — |
| Jun 2028 | -0.12 | — | -0.12 | -0.12 | 1 | — |
Forward P/E uses the fetch-time price divided by consensus EPS (quarter annualised ×4). Revision score = (upgrades − downgrades) / estimates, from Nasdaq 4-week counts. Source: Nasdaq analyst data
Last updated: 2026-11-21 · Source: SEC EDGAR Form 13F-HR
As of Q3 2026, 21 SEC-registered investment managers reported holding ATHE (ALTERITY THERAPEUTICS) in their latest 13F filings, with a combined reported value of $1.04M across 284.33K shares. That is -0.7% by share count (-1.36K shares) versus the previous quarter, while reported value moved -32.5%. Ownership is concentrated: the five largest holders account for 94.5% of reported value and the top ten for 99.9%.
Compared with the prior quarter, 6 opened new positions, 3 added to existing stakes, 2 trimmed, 6 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q3 2026, not real-time trading.
Major shareholders of ALTERITY THERAPEUTICS (ATHE) include Twin Lakes Capital Management, LLC, Point72 Asset Management, Pinnacle Financial Group, Inc., ranked by reported 13F value among the 39 institutional holders on this page.
ATHE is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 21 | 284.33K | $1.04M | -0.7% |
| Q2 2026 | 21 | 392.69K | $2.11M | +17.6% |
| Q1 2026 | 14 | 318.97K | $1.11M | -0.4% |
| Q4 2025 | 16 | 320.22K | $986.27K | -3.1% |
| Q3 2025 | 15 | 329.80K | $1.24M | +174.9% |
| Q2 2025 | 11 | 221.83K | $906.95K | +6.8% |
| Q1 2025 | 12 | 241.71K | $833.89K | +94.4% |
| Q4 2024 | 12 | 124.26K | $415.82K | -4.8% |
Over the 8 quarters shown, institutional share counts increased 129% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q3 2025 (+174.9%).
Top Institutional Holders (Q3 2026) — 21 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 75.44K | $275.37K | 0.03% | New | |
| 62.00K | $226.30K | 0.00% | Hold | |
| 58.46K | $213.38K | 0.00% | Hold | |
| 57.24K | $208.93K | 0.00% | Reduce | |
| 15.35K | $56.02K | 0.00% | Add | |
| 11.83K | $42.81K | 0.00% | New | |
| 2.01K | $7.27K | 0.00% | Hold | |
| 1.43K | $5.21K | 0.00% | Reduce | |
| 236 | $858 | 0.00% | Add | |
| 100 | $365 | 0.00% | New | |
| 68 | $246 | 0.00% | Hold | |
| 49 | $179 | 0.00% | New | |
| 43 | $156 | 0.00% | Add | |
| 40 | $146 | 0.00% | Hold | |
| 21 | $77 | 0.00% | Hold | |
| 6 | $22 | 0.00% | Hold | |
| 5 | $18 | 0.00% | New | |
| 3 | $11 | 0.00% | New | |
| 1 | $4 | 0.00% | Hold | |
| 1 | $4 | 0.00% | Hold | |
| 1 | $4 | 0.00% | Hold |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 21 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 139.26K | $747.82K | 0.29% | Hold | |
| 63.06K | $338.66K | 0.00% | Add | |
| 62.00K | $332.94K | 0.00% | Add | |
| 58.46K | $313.93K | 0.00% | Hold | |
| 37.60K | $201.90K | 0.00% | Add | |
| 17.29K | $92.00K | 0.00% | New | |
| 10.24K | $54.98K | 0.00% | Add | |
| 2.31K | $12.40K | 0.00% | Add | |
| 2.01K | $10.79K | 0.00% | Add | |
| 200 | $1.07K | 0.00% | New | |
| 73 | $392 | 0.00% | New | |
| 68 | $362 | 0.00% | Hold | |
| 40 | $215 | 0.00% | Hold | |
| 39 | $205 | 0.00% | Add | |
| 21 | $113 | 0.00% | Hold | |
| 6 | $32 | 0.00% | Hold | |
| 5 | $27 | 0.00% | New | |
| 1 | $6 | 0.00% | New | |
| 1 | $5 | 0.00% | New | |
| 1 | $5 | 0.00% | Hold | |
| 1 | $5 | 0.00% | New |
Q1 2026 — 14 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 139.26K | $484.62K | 0.22% | Hold | |
| 58.46K | $203.44K | 0.00% | Hold | |
| 58.38K | $203.17K | 0.00% | Reduce | |
| 32.00K | $111.36K | 0.00% | Hold | |
| 20.08K | $71.47K | 0.00% | Add | |
| 6.81K | $23.70K | 0.00% | Reduce | |
| 1.97K | $7.01K | 0.00% | Reduce | |
| 1.86K | $6.46K | 0.00% | Add | |
| 68 | $240 | 0.00% | Reduce | |
| 40 | $139 | 0.00% | Hold | |
| 22 | $80 | 0.00% | Hold | |
| 21 | $73 | 0.00% | Hold | |
| 6 | $21 | 0.00% | Hold | |
| 1 | $4 | 0.00% | Hold |
Q4 2025 — 16 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 139.26K | $428.92K | 0.19% | Hold | |
| 63.68K | $196.14K | 0.00% | Reduce | |
| 58.46K | $180.06K | 0.00% | Hold | |
| 32.00K | $98.56K | 0.00% | Hold | |
| 16.81K | $51.78K | 0.00% | Reduce | |
| 6.91K | $21.28K | 0.00% | Reduce | |
| 2.13K | $6.55K | 0.00% | Add | |
| 790 | $2.43K | 0.00% | New | |
| 81 | $247 | 0.00% | Reduce | |
| 40 | $123 | 0.00% | Hold | |
| 22 | $68 | 0.00% | Hold | |
| 21 | $65 | 0.00% | New | |
| 10 | $31 | 0.00% | New | |
| 6 | $18 | 0.00% | Hold | |
| 1 | $3 | 0.00% | Reduce | |
| 1 | $3 | 0.00% | Hold |
Q3 2025 — 15 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 139.26K | $523.61K | 0.24% | Add | |
| 68.68K | $258.24K | 0.00% | Add | |
| 58.46K | $219.81K | 0.00% | New | |
| 32.00K | $120.32K | 0.00% | Add | |
| 22.14K | $83.48K | 0.00% | New | |
| 7.31K | $27.48K | 0.00% | Reduce | |
| 886 | $3.34K | 0.00% | Add | |
| 636 | $2.40K | 0.00% | New | |
| 181 | $889 | 0.00% | Hold | |
| 177 | $666 | 0.00% | Reduce | |
| 40 | $150 | 0.00% | Hold | |
| 22 | $83 | 0.00% | New | |
| 6 | $23 | 0.00% | Hold | |
| 1 | $4 | 0.00% | Hold | |
| 1 | $4 | 0.00% | New |
Q2 2025 — 11 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 131.43K | $537.34K | 0.00% | Hold | |
| 58.30K | $238.36K | 0.00% | Add | |
| 17.00K | $69.50K | 0.00% | New | |
| 8.19K | $33.48K | 0.00% | Reduce | |
| 5.92K | $24.22K | 0.01% | Hold | |
| 628 | $2.57K | 0.00% | New | |
| 181 | $740 | 0.00% | Hold | |
| 130 | $533 | 0.00% | Hold | |
| 40 | $164 | 0.00% | Hold | |
| 6 | $25 | 0.00% | Hold | |
| 1 | $4 | 0.00% | Hold |
New Positions (Q3 2026)
- Pinnacle Financial Group, Inc. 75.44K sh · $275.37K
- XTX Topco Ltd 11.83K sh · $42.81K
- Wells Fargo & Co 100 sh · $365
- Tower Research Capital LLC (TRC) 49 sh · $179
- JPMorgan Chase & Co 5 sh · $18
- NISA INVESTMENT ADVISORS, LLC 3 sh · $11
Fully Exited (vs previous quarter)
- Twin Lakes Capital Management, LLC sold 139.26K sh · $747.82K
- Citadel Advisors sold 37.60K sh · $201.90K
- HRT FINANCIAL LP sold 17.29K sh · $92.00K
- Providence Capital Advisors, LLC sold 200 sh · $1.07K
- Integrated Wealth Concepts LLC sold 73 sh · $392
- UBS Group AG sold 5 sh · $27
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pinnacle Financial Group, Inc. | 75.44K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| GREENLEAF TRUST | 62.00K | 62.00K | 32.00K | 32.00K | 32.00K | 17.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| HB Wealth Management, LLC | 58.46K | 58.46K | 58.46K | 58.46K | 58.46K | — | 37.48K | 31.88K | 23.78K | — | — | — | — | — | — | — | — | — | — | — |
| Morgan Stanley | 57.24K | 63.06K | 58.38K | 63.68K | 68.68K | 58.30K | 43.70K | 44.40K | 44.50K | 48.40K | 51.98K | 55.08K | 51.48K | 52.19K | 53.48K | 524.36K | 546.96K | 595.26K | 579.96K | 559.86K |
| BNP PARIBAS FINANCIAL MARKETS | 15.35K | 10.24K | 6.81K | 6.91K | 7.31K | 8.19K | 9.75K | 8.79K | — | — | — | — | — | — | — | — | — | — | — | — |
| XTX Topco Ltd | 11.83K | — | — | — | — | — | — | — | — | — | 17.43K | — | — | — | — | — | — | — | — | — |
| RHUMBLINE ADVISERS | 2.01K | 2.01K | 1.97K | 2.13K | 886 | 130 | 130 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| GAMMA Investing LLC | 1.43K | 2.31K | 1.86K | 790 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Farther Finance Advisors, LLC | 236 | 39 | 22 | 22 | 22 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Wells Fargo & Co | 100 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| OSAIC HOLDINGS, INC. | 68 | 68 | 68 | 81 | 181 | 181 | 181 | 181 | 81 | 81 | 81 | 81 | 81 | — | — | — | — | — | — | — |
| Tower Research Capital LLC (TRC) | 49 | — | — | 10 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Citigroup Inc | 43 | 1 | — | 1 | 636 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Blue Trust, Inc. | 40 | 40 | 40 | 40 | 40 | 40 | 40 | 40 | 40 | — | — | — | — | — | — | — | — | — | — | — |
| CoreCap Advisors, LLC | 21 | 21 | 21 | 21 | — | — | — | — | — | 21 | 21 | — | — | — | — | — | — | — | — | — |
| Steward Partners Investment Advisory, LLC | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | — | — | — | — | — | — | — |
| JPMorgan Chase & Co | 5 | — | — | — | — | — | 53 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| NISA INVESTMENT ADVISORS, LLC | 3 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Cranbrook Wealth Management, LLC | 1 | 1 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Caitong International Asset Management Co., Ltd | 1 | 1 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold ATHE?
As of 2026-Q3, 21 institutional funds reported holding ATHE (ALTERITY THERAPEUTICS) in SEC 13F filings, with a combined reported value of $1.04M.
How many shares of ATHE do institutions own?
13F filers reported 284.33K shares of ATHE, worth $1.04M in aggregate at the end of 2026-Q3.
Is institutional ownership of ATHE rising or falling?
Share counts moved -0.7% versus the prior quarter — distribution.
Who are the top institutional holders of ATHE?
The largest 13F holders are Twin Lakes Capital Management, LLC, Point72 Asset Management, Pinnacle Financial Group, Inc., GREENLEAF TRUST, HB Wealth Management, LLC; the top 25 are ranked at the top of this page.
Who are the major shareholders of ALTERITY THERAPEUTICS?
The major shareholders of ALTERITY THERAPEUTICS (ATHE) by reported 13F value are Twin Lakes Capital Management, LLC, Point72 Asset Management, Pinnacle Financial Group, Inc., GREENLEAF TRUST, HB Wealth Management, LLC, among 39 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.